Rennova Health Stock Book Value Per Share
| RNVADelisted Stock | USD 0.0001 0.00 0.00% |
Rennova Health fundamentals help investors to digest information that contributes to Rennova Health's financial success or failures. It also enables traders to predict the movement of Rennova Pink Sheet. The fundamental analysis module provides a way to measure Rennova Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rennova Health pink sheet.
Rennova |
Rennova Health Company Book Value Per Share Analysis
Rennova Health's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Rennova Health Book Value Per Share | (0) X |
Most of Rennova Health's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rennova Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
CompetitionIn accordance with the recently published financial statements, the book value per share of Rennova Health is about -0.002 times. This is 99.88% lower than that of the Health Care Providers & Services sector and 100.0% lower than that of the Health Care industry. The book value per share for all United States stocks is 100.0% higher than that of the company.
Rennova Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rennova Health's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Rennova Health could also be used in its relative valuation, which is a method of valuing Rennova Health by comparing valuation metrics of similar companies.Rennova Health is currently under evaluation in book value per share category among related companies.
Rennova Fundamentals
| Return On Asset | -0.0862 | ||||
| Profit Margin | (0.53) % | ||||
| Operating Margin | (0.30) % | ||||
| Current Valuation | 18.13 M | ||||
| Shares Outstanding | 29.08 B | ||||
| Shares Owned By Institutions | 9.00 % | ||||
| Price To Earning | (0.03) X | ||||
| Price To Sales | 0 X | ||||
| Revenue | 3.22 M | ||||
| Gross Profit | (2.07 M) | ||||
| EBITDA | (1.08 M) | ||||
| Net Income | (5.09 M) | ||||
| Cash And Equivalents | 126.88 K | ||||
| Total Debt | 15.17 M | ||||
| Debt To Equity | 0.81 % | ||||
| Current Ratio | 0.10 X | ||||
| Book Value Per Share | (0) X | ||||
| Cash Flow From Operations | (8.91 M) | ||||
| Short Ratio | 0.84 X | ||||
| Earnings Per Share | (333.88) X | ||||
| Target Price | 555.0 | ||||
| Number Of Employees | 57 | ||||
| Beta | 53.11 | ||||
| Market Capitalization | 2.91 M | ||||
| Total Asset | 19.63 M | ||||
| Retained Earnings | (133.25 M) | ||||
| Working Capital | 6.86 M | ||||
| Current Asset | 7.7 M | ||||
| Current Liabilities | 841 K | ||||
| Z Score | -8.4 | ||||
| Net Asset | 19.63 M |
About Rennova Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rennova Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rennova Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rennova Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as various price indices. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Rennova Pink Sheet
If you are still planning to invest in Rennova Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rennova Health's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |